Nicholas R. Payne

Nicholas R. Payne

Auto-generated profile, based on publicly available information

Nicholas R. Payne

Department of Radiology, University of Cambridge School of Clinical Medicine, Box 218, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2024 in Radiology
Verified
Journal Article
Closed access
MNMuzna Nanaa
Muzna Nanaa
VGVaishnavi O. Gupta
Vaishnavi O. Gupta
SHSarah E. Hickman
Sarah E. Hickman
IAIris Allajbeu
Iris Allajbeu
NPNicholas R. Payne
Nicholas R. Payne
FGFiona J. Gilbert
Fiona J. Gilbert
An artificial intelligence algorithm accurately detected one-quarter of interval cancers on screening mammograms and accurately located three-quarters of them, which could result in earlier detection of breast cancer.

6 February 2025 in Communications Medicine
Verified
Journal Article
Open access
PDF file
OSOliver Lester Saldanha
Oliver Lester Saldanha
JZJiefu Zhu
Jiefu Zhu
GMGustav Müller-Franzes
Gustav Müller-Franzes
ZCZunamys I. Carrero
Zunamys I. Carrero
NPNicholas R. Payne
Nicholas R. Payne
JKJakob Nikolas Kather
Jakob Nikolas Kather
Background: Over the next 5 years, new breast cancer screening guidelines recommending magnetic resonance imaging (MRI) for certain patients will significantly increase the volume of imaging data to be analyzed. While this increase poses challenges for radiologists, artificial intelligence (AI) offers potential solutions to manage this workload. However, the development of AI models is often hindered by manual annotation requirements and strict data-sharing regulations between institutions. Methods: In this study, we present an integrated pipeline combining weakly supervised learning—reducing the need for detailed annotations—with local AI model training via swarm learning (SL), which circumvents centralized data sharing. We utilized three datasets comprising 1372 female bilateral breast MRI exams from institutions in three countries: the United States (US), Switzerland, and the United Kingdom (UK) to train models. These models were then validated on two external datasets consisting of 649 bilateral breast MRI exams from Germany and Greece. Results: Upon systematically benchmarking various weakly supervised two-dimensional (2D) and three-dimensional (3D) deep learning (DL) methods, we find that the 3D-ResNet-101 demonstrates superior performance. By implementing a real-world SL setup across three international centers, we observe that these collaboratively trained models outperform those trained locally. Even with a smaller dataset, we demonstrate the practical feasibility of deploying SL internationally with on-site data processing, addressing challenges such as data privacy and annotation variability. Conclusions: Combining weakly supervised learning with SL enhances inter-institutional collaboration, improving the utility of distributed datasets for medical AI training without requiring detailed annotations or centralized data sharing.

1 November 2024 in Radiology
Verified
Journal Article
Closed access
SHSarah E. Hickman
Sarah E. Hickman
NPNicholas R. Payne
Nicholas R. Payne
RBRichard T. Black
Richard T. Black
YHYuan Huang
Yuan Huang
APAndrew Nicholas Priest
Andrew Nicholas Priest
FGFiona J. Gilbert
Fiona J. Gilbert
Stand-alone deep learning algorithms achieved noninferior performance as individual readers and, when combined with human readers, matched double-reading accuracy in mammographic screening.

1 October 2025 in Radiology
Verified
Journal Article
Closed access
JRJoshua Rothwell
Joshua Rothwell
PRPriya Rogers
Priya Rogers
NPNicholas R. Payne
Nicholas R. Payne
YHYuan Huang
Yuan Huang
JKJoshua D. Kaggie
Joshua D. Kaggie
FGFiona J. Gilbert
Fiona J. Gilbert
The results of this study support the use of generalized risk scores from mammography-based deep learning models to identify women who may benefit from supplemental imaging or shorter screening intervals for earlier detection of interval breast cancers.